The Hospital Research Foundation Group is proud to announce a $195,000 commitment to help people live well after bowel cancer.
There are more than 15,000 people diagnosed with bowel cancer each year in Australia – the third most commonly diagnosed cancer.
Despite early detection improving survival rates, the ongoing side effects from treatment can affect people’s physical, social and psychological health.
Funding focused on survivorship and quality of life
Thanks to our generous donors, two new research grants have been announced as part of this commitment. Both projects aim to improve quality of life by managing ongoing symptoms such as fatigue and nerve pain following bowel cancer treatment.
The two new projects include:
Dr Matthew Wallen – Improving fatigue through digital physical activity
Flinders University
Fatigue is a common and debilitating symptom among bowel cancer survivors, often affecting physical activity, emotional wellbeing, and overall quality of life.
This world-first study will co-design, implement, and evaluate a remotely delivered, individualised digital physical activity program to reduce fatigue and support long-term recovery.
Professor Joanne Bowen – Improving treatment for ongoing nerve pain
University of Adelaide
Bowel cancer patients who undergo chemotherapy often experience ongoing nerve pain, in a condition called chemotherapy-induced peripheral neuropathy (CIPN).
CIPN has no treatments. This project will be the first to test a brain modulation therapy called transcranial magnetic stimulation (TMS). Prof Bowen and her team will determine whether pain is improved using TMS and work towards expanding this approach for cancer survivors.
These life-changing projects are made possible by the generosity of our donors, fundraisers, partners, and ticket buyers in The Hospital Research Foundation Home Lottery. Your support is helping to shape a brighter, healthier future for bowel cancer survivors.
